To confirm that CXCR4 plays a role in acquired trastuzumab resistance, we re-created trastuzumab-resistant breast cancer models via continuous exposure of the trastuzumab-sensitive cells to trastuzumab (20 μg/ml) for at least 1 year. The gene discussed is CXCR4; the disease is breast carcinoma.